{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000176","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.010487+00:00","generated_at":"2026-05-16T11:49:14.372362+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Intelligent Bio Solutions closes $10M private placement; funds FDA submission and expansion","bullets":["Gross proceeds of ~$10M from sale of 2,298,850 units at $4.35/unit (common/pre-funded warrant + two Series K warrants).","At closing, 105,000 shares and 2,193,850 pre-funded warrants issued; post-closing shares outstanding ~1.2M (excluding warrants).","Series K warrants exercisable at $4.10/share for 5 years after registration statement declared effective by SEC.","CEO: proceeds to fund FDA 510(k) submission for fingerprint drug screening system and international market expansion.","Closing on Jan 2, 2026; resale registration statement to be filed by Jan 10, effective by Feb 14, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000176","json":"https://secwatch.observer/filing/0001493152-26-000176.json","markdown":"https://secwatch.observer/filing/0001493152-26-000176.md","text":"https://secwatch.observer/filing/0001493152-26-000176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/0001493152-26-000176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:49:14.372362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cac044c51e63aa88020bbcb4d3b301db31276873","claim":"INTELLIGENT BIO SOLUTIONS INC. entered into Securities Purchase Agreement with two healthcare focused institutional investors valued at approximately $10.0 million (effective 2025-12-31).","evidence_excerpt":"On December 31, 2025, Intelligent Bio Solutions Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with two healthcare focused institutional investors for the sale by the Company of (i) 2,298,850 shares (the “Shares”) of the Company’s common stock (or Series L Pre-funded warrants in lieu thereof (the “Pre-Funded Warrants”)), par value $0.01 per share (the “Common Stock”), (ii) Series K-1 warrants to purchase up to an aggregate of 2,298,850 shares of Common Stock (the “Series K-1 Warrants”), and (iii) Series K-2 warrants to purchase up to an aggregate of 2,298,850 shares of Common Stock (the “Series K-2 Warrants” and, collectively with the Series K-1 Warrants and Pre-Funded Warrants, the “Warrants”), in a private placement offering (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226000176/0001493152-26-000176-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"two healthcare focused institutional investors"},{"label":"Value","value":"approximately $10.0 million"},{"label":"Effective","value":"2025-12-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}